PharPoint Research

Executive Summary

PharPoint Research is a US-based contract research organization (CRO) founded in 2007 and headquartered in Raleigh, North Carolina. Specializing in biometrics, clinical operations, and consulting for Phase I-IV studies, the company has built a reputation for transparency, cross-functional alignment, and reliable data delivery. As a private entity in the early commercial stage (Phase 1), PharPoint operates in the competitive CRO market, serving pharmaceutical and biotechnology sponsors. With a focused service offering and a collaborative approach, the company is positioned to capture niche opportunities in clinical trial management, particularly in biostatistics and data management. While its private status limits visibility, its established presence in North Carolina’s biotech hub and emphasis on rapid timelines suggest potential for steady growth through repeat business and referrals. However, the lack of disclosed funding rounds or public financials makes it challenging to assess scalability. Overall, PharPoint Research appears to be a stable, operationally focused CRO with moderate upside potential in the clinical research outsourcing sector.

Upcoming Catalysts (preview)

• Q4 2026Major Phase III trial biometrics contract win35% success
• Q2 2027Expansion of service offerings into decentralized trial support25% success